InvestorsHub Logo
Followers 30
Posts 2469
Boards Moderated 0
Alias Born 01/02/2014

Re: None

Wednesday, 05/04/2016 7:50:54 AM

Wednesday, May 04, 2016 7:50:54 AM

Post# of 689
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Three Additional Notices of Allowance With Claims Covering PENNSAID(R) (diclofenac sodium topical solution) 2% w/w

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.